Dirk Johannes Schaefer

Dirk Johannes Schaefer

Auto-generated profile, based on publicly available information

Dirk Johannes Schaefer

Department of Plastic, Reconstructive, Aesthetic, and Hand Surgery, University Hospital Basel, 4031 Basel, Switzerland

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2020 in Cells
Verified
Journal Article
Open access
PDF file
AHAlois Hopf
Alois Hopf
DSDirk J. Schaefer
Dirk J. Schaefer
DKDaniel F. Kalbermatten
Daniel F. Kalbermatten
Raphael GuzmanRaphael Guzman
Raphael Guzman
Srinivas MadduriSrinivas Madduri
Srinivas Madduri
Functional recovery after neurotmesis, a complete transection of the nerve fiber, is often poor and requires a surgical procedure. Especially for longer gaps (>3 mm), end-to-end suturing of the proximal to the distal part is not possible, thus requiring nerve graft implantation. Artificial nerve grafts, i.e., hollow fibers, hydrogels, chitosan, collagen conduits, and decellularized scaffolds hold promise provided that these structures are populated with Schwann cells (SC) that are widely accepted to promote peripheral and spinal cord regeneration. However, these cells must be collected from the healthy peripheral nerves, resulting in significant time delay for treatment and undesired morbidities for the donors. Therefore, there is a clear need to explore the viable source of cells with a regenerative potential similar to SC. For this, we analyzed the literature for the generation of Schwann cell-like cells (SCLC) from stem cells of different origins (i.e., mesenchymal stem cells, pluripotent stem cells, and genetically programmed somatic cells) and compared their biological performance to promote axonal regeneration. Thus, the present review accounts for current developments in the field of SCLC differentiation, their applications in peripheral and central nervous system injury, and provides insights for future strategies.

1 December 2020 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
CPCarlos A. Penno
Carlos A. Penno
PJPetra Jäger
Petra Jäger
CLClaire Laguerre
Claire Laguerre
FHFranziska Hasler
Franziska Hasler
AHAndreas Hofmann
Andreas Hofmann
TRTill A. Röhn
Till A. Röhn

23 June 2018 in In Vivo
Verified
Journal Article
Closed access
COCarlo M. Oranges
Carlo M. Oranges
BLBarbara Ling
Barbara Ling
MTMathias Tremp
Mathias Tremp
RWReto Wettstein
Reto Wettstein
DKDaniel F. Kalbermatten
Daniel F. Kalbermatten
DSDirk J. Schaefer
Dirk J. Schaefer
Background: The radial forearm flap (RFF) and the anterolateral thigh flap (ALT) are commonly used for the reconstruction of head and neck soft-tissue defects. The aim of the study was to investigate and compare the surgical outcomes, complications and systemic condition of the patient after reconstruction of extensive head and neck defects with ALT or RFF following cancer extirpation. Patients and Methods: Between August 2011 and November 2013, a total of 36 patients affected by head and neck cancer (31 males and five females; mean age=64.7 years, range=40-86 years) underwent microsurgical reconstruction with 29 RFF and 10 ALT procedures. The surgical outcomes and complications among these two groups were retrospectively analyzed. Results: The success rate was 97% for the RFF group and 90% for the ALT group, with one total flap loss in each group. Donor-site complications occurred in 6% of the RFF group and in 7% of the ALT group. Seven RFF-treated patients (24%) and two treated with ALT (20%) experienced systemic complications. Statistical analysis confirmed no significant difference between the two groups regarding the variables investigated (p>0.05). Conclusion: In our experience, ALT and RFF demonstrated analogous practicability and reliability for the reconstruction of head and neck soft-tissue defects, with similar local and systemic complications and donor-site morbidity rates.

2 December 2021 in International Journal of Bioprinting
Verified
Journal Article
Open access
PDF file
LWLeonie Waldburger
Leonie Waldburger
RSRomain Schaller
Romain Schaller
CFChristina Furthmüller
Christina Furthmüller
LSLorena Schrepfer
Lorena Schrepfer
DSDirk J. Schaefer
Dirk J. Schaefer
AKAlexandre Kaempfen
Alexandre Kaempfen
In this randomized controlled pilot trial, we compared three-dimensional (3D)-printed made-to-measure splints to conventional custom-made thermoplastic splints. In a clinical setting, we evaluated their general applicability and possible benefits for immobilization in hand surgical patients. We included 20 patients with an indication for immobilization of at least 4 weeks, regardless of the splint design. Patient comfort and satisfaction were assessed with questionnaires at splint fitting, as well as 2 and 4–6 weeks later. The 3D splints were designed and printed in-house with polylactic acid from a 3D surface scan. Our data suggest that 3D-printed splinting is feasible, and patient satisfaction ratings were similar for 3D-printed and thermoplastic splints. The 3D splint production process needs to be optimized and other materials need to be tested before routine implementation is possible or more patients can be enrolled in further studies. Validated quality assessment tools for current splinting are lacking, and further investigation is necessary

22 June 2018 in World Journal of Emergency Surgery
Verified
Journal Article
Open access
PDF file
CWChristian Wetterauer
Christian Wetterauer
JEJan Ebbing
Jan Ebbing
AHA. Halla
A. Halla
RKR. Kuehl
R. Kuehl
SES. Erb
S. Erb
HSH. H. Seifert
H. H. Seifert
Fournier’s gangrene (FG) is a life-threatening infection of the genital, perineal, and perianal regions with a morbidity range between 3 and 67%. Our aim is to report our experience in treatment of FG and to assess whether three different scoring systems can accurately predict mortality and morbidity in FG patients. All patients that were treated for FG at the Department of Urology of the University Hospital Basel between June 2012 and March 2017 were included and assessed retrospectively by chart review. Furthermore, we calculated Fournier’s Gangrene Severity Index (FGSI), the Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC), and the neutrophil–lymphocyte ratio (NLR) in every patient and assessed whether those scores correlate with the patients’ morbidity and mortality. Twenty patients were included, with a median (IQR) age of 66 (46–73) years. Fifteen of twenty (75%) patients required treatment on an intensive care unit, and three died (mortality rate: 15%). The mean FGSI, LRINEC, and NLR scores were 13.0, 9.3, and 45.3 for non-survivors and 7.7, 6.5, and 26 for survivors, respectively. None of the risk scores correlated significantly with mortality; however, all three significantly correlated with infection- and surgically-induced morbidity. In our series, Fournier’s gangrene was associated with a mortality rate of 15% despite maximum multidisciplinary therapy at a specialized center. All risk scores were able to predict the morbidity of the disease in terms of local extent and the required surgical measures.

Verified
Journal Article
Open access
PDF file
AKAlexandre Kaempfen
Alexandre Kaempfen
ATAtanas Todorov
Atanas Todorov
SGSinan Güven
Sinan Güven
RLRené D. Largo
René D. Largo
Claude JaquiéryClaude Jaquiéry
Claude Jaquiéry
DSDirk J. Schaefer
Dirk J. Schaefer
The gold standard treatment of large segmental bone defects is autologous bone transfer, which suffers from low availability and additional morbidity. Tissue engineered bone able to engraft orthotopically and a suitable animal model for pre-clinical testing are direly needed. This study aimed to evaluate engraftment of tissue-engineered bone with different prevascularization strategies in a novel segmental defect model in the rabbit humerus. Decellularized bone matrix (Tutobone) seeded with bone marrow mesenchymal stromal cells was used directly orthotopically or combined with a vessel and inserted immediately (1-step) or only after six weeks of subcutaneous “incubation” (2-step). After 12 weeks, histological and radiological assessment was performed. Variable callus formation was observed. No bone formation or remodeling of the graft through TRAP positive osteoclasts could be detected. Instead, a variable amount of necrotic tissue formed. Although necrotic area correlated significantly with amount of vessels and the 2-step strategy had significantly more vessels than the 1-step strategy, no significant reduction of necrotic area was found. In conclusion, the animal model developed here represents a highly challenging situation, for which a suitable engineered bone graft with better prevascularization, better resorbability and higher osteogenicity has yet to be developed.